XWELL (NASDAQ:XWEL) Shares Down 1.9% – Should You Sell?

Shares of XWELL, Inc. (NASDAQ:XWEL) fell 1.9% during mid-day trading on Thursday . The company traded as low as $1.0450 and last traded at $1.05. 9,468 shares changed hands during trading, a decline of 96% from the average session volume of 216,249 shares. The stock had previously closed at $1.07.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on XWEL shares. Wall Street Zen cut XWELL from a “hold” rating to a “sell” rating in a report on Sunday, May 17th. Weiss Ratings lowered XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 13th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

XWELL Stock Down 1.9%

The firm has a market cap of $8.86 million, a PE ratio of -0.19 and a beta of 1.03. The firm’s fifty day simple moving average is $1.18 and its two-hundred day simple moving average is $1.02.

XWELL (NASDAQ:XWEL) last posted its quarterly earnings results on Wednesday, May 20th. The company reported ($1.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.51). The firm had revenue of $6.64 million during the quarter, compared to the consensus estimate of $2.37 million. XWELL had a negative return on equity of 2,318.99% and a negative net margin of 81.43%.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.